Erlotinib HCl (Generic for Tarceva)

Introducing Erlotinib HCl, the generic for Tarceva, Anti-Cancer Tablet – a selective tyrosine kinase inhibitor targeted at EGFR-mutated non-small cell lung cancer. It blocks aberrant signaling pathways responsible for tumor proliferation and survival. Experience significant tumor regression, improved progression-free survival, and enhanced quality of life with this advanced, targeted therapeutic agent.